Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Besifovir dipivoxil maleate: a novel antiviral agent with low toxicity and high genetic barriers for chronic hepatitis B

Published:2021-08-19 Issue:18 Volume:22 Page:2427-2433
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Song Jeong Eun¹,Park Jun Yong²³⁴^ORCID

Affiliation:

1. Department Of Internal Medicine, Daegu Catholic University School Of Medicine, Daegu, Korea

2. Department Of Internal Medicine, Yonsei University College Of Medicine, Seoul, Korea

3. Institute Of Gastroenterology, Yonsei University College Of Medicine, Seoul, Korea

4. Yonsei Liver Center, Severance Hospital, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2021.1967321

Reference31 articles.

1. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

2. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

3. Chronic hepatitis B virus infection in the Asia-Pacific region and Africa: Review of disease progression

4. Viral hepatitis B

5. Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy;Cancers;2024-02-22

2. The progress of molecules and strategies for the treatment of HBV infection;Frontiers in Cellular and Infection Microbiology;2023-03-15

3. Susceptibility of Drug Resistant Hepatitis B Virus Mutants to Besifovir;Biomedicines;2022-07-07

4. RETRACTED ARTICLE: Analysis of antiviral efficacy after switching from brand to generic entecavir in patients with treatment-naïve chronic hepatitis B;BMC Gastroenterology;2022-05-10

5. Identification and Characterization of Besifovir-Resistant Hepatitis B Virus Isolated from a Chronic Hepatitis B Patient;Biomedicines;2022-01-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3